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The rational regulation of protein concentration remains an elusive problem in synthetic biology.  Several 
strategies have been developed at the transcriptional level, but these suffer from suboptimal response kinetics 
due to slow turnover of any protein already synthesized.  The direct fusion of degradation tags to a protein of 
interest (POI) results in rapid fluctuations in protein concentration, and several degradation tags have been 
developed that function conditionally on the presence of a small molecule.  However, no solutions currently exist 
that allow the intracellular concentration of a POI to be regulated by the cellular environment. 
 
To that end, we propose a conditional protein rescue (CPR) system: a 
protein modulator capable of translating information concerning endogenous 
cellular proteins to desirable changes in the concentration of a POI.  The POI 
is fused to a destabilizing domain (DD) and a small sensor domain, a 
product which—by virtue of the DD—is inherently unstable via proteasomal 
degradation (Figure 1, top).  In the absence of the sensor’s target, the 
protein remains unstable and exists at low intracellular concentrations 
(Figure 1, bottom left with curtain open revealing the DD).  When the 
sensor’s target is present, the interaction with the sensor sterically masks the 
DD and rescues the POI from degradation (Figure 1, bottom right with closed 
curtain in the windowpane concealing the DD). 
 
As an initial proof-of-concept, we used YFP as our POI and the short peptide 
SpyTag as the sensor.  When SpyTag interacts with its target, SpyCatcher, a 
covalent bond is formed, providing maximum bond strength and thus optimal 
conditions for CPR to occur.  YFP levels remained low in the absence of 
SpyCatcher, and upon co-expression with SpyCatcher, YFP levels rose 
rapidly indicating CPR functions as predicted.  Furthermore, adding an 
ubiquitin-like (UbL) domain to the N-terminus of YFP enhanced the 
degradation kinetics and reduced background to undetectable levels while 
still allowing for rescue in the presence of SpyCatcher.  This indicates that CPR is modular with tunable 
sensitivity to meet the needs of the circumstance. 
 
Cancer is often marked by dramatic changes in a cell’s proteome.  If this information could be accurately 
translated into a therapeutic output, then that technology opens the door to a next generation of “smart 
therapeutics”.  To demonstrate this conceptually, we changed the sensor in CPR to a camel single-domain 
antibody fragment (nanobody), a small, monomeric protein with high specificity towards its antigen.  As an 
output POI, we chose yeast cytosine deaminase (yCD), a prodrug converting enzyme capable of converting the 
innocuous prodrug 5-fluorocytosine (5-FC) to the cytotoxic drug 5-fluorouracil (5-FU).  GFP served as a visually 
traceable cancer-protein surrogate and the target of a well characterized nanobody.  The nanobody was not 
large enough to effect protein degradation, and no cytotoxicity was observed in the absence of GFP, even when 
5-FC was administered.  However, when GFP was co-expressed, cell death was observed on levels similar to 
when 5-FU was administered directly.  This demonstrates that CPR can be used to control a wide variety of 
proteins. 
 
In summary, CPR represents a crucial first step towards the conditional control of intracellular protein 
concentration, and it serves as a novel modulator between endogenous proteome information and a desired 
output protein.  CPR could fill a much need niche in synthetic biology as the field begins to tackle personalized 
medicine, autonomous cell manufacturing, and other bioengineering challenges.  This process can be expanded 
to other proteasomal degradation mechanisms, and the layering of them presents the opportunity for building 
protein-based Boolean logic gates for more complex decision making applications. 
Figure 1 – Protein-based 
modulator for translating 
between endogenous cellular 
information and the 
concentration of a protein of 
interest. 
